Intellia Therapeutics Inc (NTLA)
23.59
+0.30
(+1.29%)
USD |
NASDAQ |
May 03, 16:00
23.59
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Free Cash Flow: -408.07M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -408.07M |
| September 30, 2023 | -407.28M |
| June 30, 2023 | -384.33M |
| March 31, 2023 | -378.78M |
| December 31, 2022 | -391.68M |
| September 30, 2022 | -355.42M |
| June 30, 2022 | -342.21M |
| March 31, 2022 | -309.06M |
| December 31, 2021 | -237.79M |
| September 30, 2021 | -221.50M |
| June 30, 2021 | -181.20M |
| March 31, 2021 | -68.90M |
| December 31, 2020 | -53.50M |
| September 30, 2020 | -43.50M |
| June 30, 2020 | -41.44M |
| March 31, 2020 | -126.44M |
| December 31, 2019 | -110.03M |
| Date | Value |
|---|---|
| September 30, 2019 | -88.93M |
| June 30, 2019 | -76.20M |
| March 31, 2019 | -70.98M |
| December 31, 2018 | -67.62M |
| September 30, 2018 | -81.19M |
| June 30, 2018 | -85.87M |
| March 31, 2018 | -79.43M |
| December 31, 2017 | -75.37M |
| September 30, 2017 | -69.48M |
| June 30, 2017 | -58.54M |
| March 31, 2017 | 24.81M |
| December 31, 2016 | 29.94M |
| September 30, 2016 | 41.42M |
| June 30, 2016 | 45.76M |
| March 31, 2016 | -19.05M |
| December 31, 2015 | -4.317M |
Free Cash Flow Range, Past 5 Years
-408.07M
Minimum
Dec 2023
-41.44M
Maximum
Jun 2020
-222.43M
Average
-221.50M
Median
Sep 2021
Free Cash Flow Benchmarks
| Moderna Inc | -3.825B |
| Regeneron Pharmaceuticals Inc | 3.668B |
| NeuroMetrix Inc | -6.268M |
| Repligen Corp | 109.54M |
| Pacific Biosciences of California Inc | -268.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -93.05M |
| Cash from Investing (Quarterly) | 45.94M |
| Cash from Financing (Quarterly) | 106.48M |
| Free Cash Flow Per Share (Quarterly) | -1.017 |
| Free Cash Flow to Equity (Quarterly) | -94.57M |
| Free Cash Flow Yield | -19.35% |